# Canadian Pacific Kansas City Ltd: financial statements, quarterly

CP · NYSE · CIK 16875 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cp.md) · [Financials](/companies/cp/financials.md) · [Filings](/companies/cp/filings.md) · [Insiders](/companies/cp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,305](/filings/0000016875-24-000033.md) | [3,753 d](/filings/0000016875-26-000008.md) | [3,490](/filings/0000016875-25-000018.md) | [3,577](/filings/0000016875-25-000032.md) | [3,503](/filings/0000016875-25-000039.md) | [3,844 d](/filings/0000016875-26-000008.md) | [3,768](/filings/0000016875-26-000015.md) | [3,673](/filings/0000016875-26-000026.md) | [3,634](/filings/0000016875-25-000039.md) | [3,894 d](/filings/0000016875-26-000008.md) | [3,673](/filings/0000016875-26-000015.md) | [4,137](/filings/0000016875-26-000026.md) |
| Operating income | $m | [1,173](/filings/0000016875-24-000033.md) | [1,442 d](/filings/0000016875-26-000008.md) | [1,149](/filings/0000016875-25-000018.md) | [1,267](/filings/0000016875-25-000032.md) | [1,203](/filings/0000016875-25-000039.md) | [1,560 d](/filings/0000016875-26-000008.md) | [1,317](/filings/0000016875-26-000015.md) | [1,343](/filings/0000016875-26-000026.md) | [1,336](/filings/0000016875-25-000039.md) | [1,613 d](/filings/0000016875-26-000008.md) | [1,258](/filings/0000016875-26-000015.md) | [1,472](/filings/0000016875-26-000026.md) |
| Income tax | $m | [258](/filings/0000016875-24-000033.md) | [275 d](/filings/0000016875-26-000008.md) | [259](/filings/0000016875-25-000018.md) | [292](/filings/0000016875-25-000032.md) | [262](/filings/0000016875-25-000039.md) | [246 d](/filings/0000016875-26-000008.md) | [292](/filings/0000016875-26-000015.md) | [357](/filings/0000016875-26-000026.md) | [296](/filings/0000016875-25-000039.md) | [400 d](/filings/0000016875-26-000008.md) | [275](/filings/0000016875-26-000015.md) | [335](/filings/0000016875-26-000026.md) |
| Net income | $m | [780](/filings/0000016875-24-000033.md) | [1,023 d](/filings/0000016875-26-000008.md) | [775](/filings/0000016875-25-000018.md) | [905](/filings/0000016875-25-000032.md) | [837](/filings/0000016875-25-000039.md) | [1,201 d](/filings/0000016875-26-000008.md) | [910](/filings/0000016875-26-000015.md) | [1,234](/filings/0000016875-26-000026.md) | [920](/filings/0000016875-25-000039.md) | [1,077 d](/filings/0000016875-26-000008.md) | [846](/filings/0000016875-26-000015.md) | [1,024](/filings/0000016875-26-000026.md) |
| Diluted EPS | $ per share | [0.84](/filings/0000016875-24-000033.md) | not reported | [0.83](/filings/0000016875-25-000018.md) | [0.97](/filings/0000016875-25-000032.md) | [0.90](/filings/0000016875-25-000039.md) | not reported | [0.97](/filings/0000016875-26-000015.md) | [1.33](/filings/0000016875-26-000026.md) | [1.01](/filings/0000016875-25-000039.md) | not reported | [0.94](/filings/0000016875-26-000015.md) | [1.15](/filings/0000016875-26-000026.md) |
| Basic EPS | $ per share | [0.84](/filings/0000016875-24-000033.md) | not reported | [0.83](/filings/0000016875-25-000018.md) | [0.97](/filings/0000016875-25-000032.md) | [0.90](/filings/0000016875-25-000039.md) | not reported | [0.98](/filings/0000016875-26-000015.md) | [1.34](/filings/0000016875-26-000026.md) | [1.01](/filings/0000016875-25-000039.md) | not reported | [0.94](/filings/0000016875-26-000015.md) | [1.16](/filings/0000016875-26-000026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0000016875-23-000044.md) | [0.5](/filings/0000016875-25-000008.md) | [0.5](/filings/0000016875-24-000016.md) | [0.6](/filings/0000016875-24-000026.md) | [0.5](/filings/0000016875-24-000033.md) | [0.7](/filings/0000016875-26-000008.md) | [0.7](/filings/0000016875-25-000018.md) | [0.8](/filings/0000016875-25-000032.md) | [0.4](/filings/0000016875-25-000039.md) | [0.2](/filings/0000016875-26-000026.md) | [0.4](/filings/0000016875-26-000015.md) | [0.4](/filings/0000016875-26-000026.md) |
| Current assets | $bn | [3.1](/filings/0000016875-23-000044.md) | [3.0](/filings/0000016875-25-000008.md) | [3.1](/filings/0000016875-24-000016.md) | [3.2](/filings/0000016875-24-000026.md) | [3.1](/filings/0000016875-24-000033.md) | [3.4](/filings/0000016875-26-000008.md) | [3.5](/filings/0000016875-25-000018.md) | [3.5](/filings/0000016875-25-000032.md) | [3.3](/filings/0000016875-25-000039.md) | [2.9](/filings/0000016875-26-000026.md) | [3.4](/filings/0000016875-26-000015.md) | [3.5](/filings/0000016875-26-000026.md) |
| Total assets | $bn | [81.0](/filings/0000016875-23-000044.md) | [79.9](/filings/0000016875-25-000008.md) | [81.7](/filings/0000016875-24-000016.md) | [82.8](/filings/0000016875-24-000026.md) | [82.2](/filings/0000016875-24-000033.md) | [87.7](/filings/0000016875-26-000008.md) | [88.0](/filings/0000016875-25-000018.md) | [85.2](/filings/0000016875-25-000032.md) | [86.7](/filings/0000016875-25-000039.md) | [85.9](/filings/0000016875-26-000026.md) | [87.7](/filings/0000016875-26-000015.md) | [89.3](/filings/0000016875-26-000026.md) |
| Current liabilities | $bn | [4.4](/filings/0000016875-23-000044.md) | [5.7](/filings/0000016875-25-000008.md) | [6.4](/filings/0000016875-24-000016.md) | [6.3](/filings/0000016875-24-000026.md) | [5.8](/filings/0000016875-24-000033.md) | [5.7](/filings/0000016875-26-000008.md) | [4.2](/filings/0000016875-25-000018.md) | [3.8](/filings/0000016875-25-000032.md) | [5.2](/filings/0000016875-25-000039.md) | [6.0](/filings/0000016875-26-000026.md) | [5.1](/filings/0000016875-26-000015.md) | [5.8](/filings/0000016875-26-000026.md) |
| Total liabilities | $bn | [38.7](/filings/0000016875-23-000044.md) | [37.5](/filings/0000016875-25-000008.md) | [37.9](/filings/0000016875-24-000016.md) | [38.0](/filings/0000016875-24-000026.md) | [37.1](/filings/0000016875-24-000033.md) | [38.9](/filings/0000016875-26-000008.md) | [38.8](/filings/0000016875-25-000018.md) | [38.0](/filings/0000016875-25-000032.md) | [40.0](/filings/0000016875-25-000039.md) | [39.1](/filings/0000016875-26-000026.md) | [40.3](/filings/0000016875-26-000015.md) | [41.7](/filings/0000016875-26-000026.md) |
| Short-term borrowings | $bn | not reported | [0.8](/filings/0000016875-24-000033.md) | not reported | not reported | not reported | [1.1](/filings/0000016875-25-000032.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [41.3](/filings/0000016875-23-000044.md) | [41.5](/filings/0000016875-25-000008.md) | [42.8](/filings/0000016875-24-000016.md) | [43.9](/filings/0000016875-24-000026.md) | [44.1](/filings/0000016875-24-000033.md) | [47.9](/filings/0000016875-26-000008.md) | [48.2](/filings/0000016875-25-000018.md) | [46.2](/filings/0000016875-25-000032.md) | [45.7](/filings/0000016875-25-000039.md) | [45.9](/filings/0000016875-26-000026.md) | [46.5](/filings/0000016875-26-000015.md) | [46.6](/filings/0000016875-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,027](/filings/0000016875-24-000033.md) | [1,336 d](/filings/0000016875-26-000008.md) | [1,015](/filings/0000016875-25-000018.md) | [1,278](/filings/0000016875-25-000032.md) | [1,272](/filings/0000016875-25-000039.md) | [1,704 d](/filings/0000016875-26-000008.md) | [1,156](/filings/0000016875-26-000015.md) | [1,355](/filings/0000016875-26-000026.md) | [1,274](/filings/0000016875-25-000039.md) | [1,524 d](/filings/0000016875-26-000008.md) | [976](/filings/0000016875-26-000015.md) | [1,726](/filings/0000016875-26-000026.md) |
| Capital expenditure | $m | [733](/filings/0000016875-24-000033.md) | [701 d](/filings/0000016875-26-000008.md) | [527](/filings/0000016875-25-000018.md) | [808](/filings/0000016875-25-000032.md) | [748](/filings/0000016875-25-000039.md) | [742 d](/filings/0000016875-26-000008.md) | [711](/filings/0000016875-26-000015.md) | [743](/filings/0000016875-26-000026.md) | [860](/filings/0000016875-25-000039.md) | [788 d](/filings/0000016875-26-000008.md) | [664](/filings/0000016875-26-000015.md) | [758](/filings/0000016875-26-000026.md) |
| Dividends paid | $m | [177](/filings/0000016875-24-000033.md) | [177 d](/filings/0000016875-26-000008.md) | [177](/filings/0000016875-25-000018.md) | [178](/filings/0000016875-25-000032.md) | [177](/filings/0000016875-25-000039.md) | [177 d](/filings/0000016875-26-000008.md) | [177](/filings/0000016875-26-000015.md) | [210](/filings/0000016875-26-000026.md) | [205](/filings/0000016875-25-000039.md) | [204 d](/filings/0000016875-26-000008.md) | [204](/filings/0000016875-26-000015.md) | [204](/filings/0000016875-26-000026.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0000016875-25-000018.md) | [0.0](/filings/0000016875-25-000032.md) | [0.0](/filings/0000016875-25-000039.md) | [0.0 d](/filings/0000016875-26-000008.md) | [347](/filings/0000016875-26-000015.md) | [1,393](/filings/0000016875-26-000026.md) | [1,805](/filings/0000016875-25-000039.md) | [397 d](/filings/0000016875-26-000008.md) | [680](/filings/0000016875-26-000015.md) | [1,283](/filings/0000016875-26-000026.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [933](/filings/0000016875-23-000044.md) | [934](/filings/0000016875-24-000016.md) | [934](/filings/0000016875-24-000026.md) | [934](/filings/0000016875-24-000033.md) | [934](/filings/0000016875-25-000018.md) | [935](/filings/0000016875-25-000032.md) | [935](/filings/0000016875-25-000039.md) | [934](/filings/0000016875-26-000015.md) | [925](/filings/0000016875-26-000026.md) | [911](/filings/0000016875-25-000039.md) | [897](/filings/0000016875-26-000015.md) | [887](/filings/0000016875-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 879,079,224 at 2026-07-28, from the cover of the [10-Q filed 2026-07-30](/filings/0000016875-26-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.